Archive for August 2018

Kid Wears Green Shirt To Picture Day, Mom Sees How Photos Turned Out & Dies Laughing

http://blog.thebreastcancersite.com/green-shirt/

“I really couldn’t believe my handsome boy’s head and arms were just floating there. I showed my husband and we got such a good laugh from it. And guess what? His smile and hair are PERFECT! HA!”… Read More

Full credit to the source URL for this article; please feel free to follow the link through to the full article.

Read More

Will Perjeta Work for You?

https://www.breastcancer.org/treatment/targeted_therapies/perjeta/for_you

Perjeta can work in people with HER2-positive, metastatic breast cancer that hasn’t been treated with Herceptin or chemotherapy yet.

Metastatic breast cancer is breast cancer that has spread to parts of the body away from the breast, such as the bones or liver.

Perjeta also can work before surgery in people with HER2-positive, early-stage (the cancer must be larger than 2 cm or cancer must be in the lymph nodes), inflammatory, or locally advanced-stage breast cancer with a high risk of metastasizing or becoming fatal.

Perjeta
also can work after surgery in people with HER2-positive early-stage breast
cancer with a high risk of recurrence.

Four different tests can be used to figure out if the cancer is HER2-positive and if it will likely respond to Perjeta:

  • IHC (ImmunoHistoChemistry)

    IHC is the most commonly used test to see if a tumor has too much of the HER2 receptor protein on the surface of the cancer cells.

    The IHC test gives a score of 0 to 3+ that indicates the amount of HER2 receptor protein in tumors. If the tumor scores 0 to 1+, it’s called “HER2 negative.” If it scores 2+ or 3+, it’s called “HER2 positive.”

    Women with IHC positive scores tend to respond favorably to Perjeta. The drug is not considered effective for tumors with IHC scores of 0 or 1+.

    It’s important to note that results on the IHC test may vary from lab to lab, and that some labs are more proficient at HER2 testing than others. Discuss with your doctor whether you might want to get a FISH test, especially if you have a 1+ or 2+ result from IHC. That way you can get another measure of whether the tumor might respond well to Perjeta.

    The IHC test results are most reliable for fresh or frozen tissue samples. IHC tends to be an unreliable way to test tissue that’s preserved in wax or other chemicals. FISH testing is the preferred way to assess preserved tissue samples.

  • FISH (Fluorescen…

    Full credit to the source URL for this article; please feel free to follow the link through to the full article.

    Read More

Radiation Therapy

https://www.breastcancer.org/treatment/radiation

<!–
Start of DoubleClick Floodlight Tag: Please do not remove
Activity name of this tag: English Treatment – F/W2012
URL of the webpage where the tag is expected to be placed: http://www.breastcancer.org/treatment/
This tag must be placed between the and tags, as close as possible to the opening tag.
Creation Date: 08/28/2012
–>

RadOvrHdMac

Radiation therapy — also called radiotherapy — is a highly targeted and highly effective way to destroy cancer cells in the breast that may stick around after surgery. Despite what many people fear, radiation therapy is relatively easy to tolerate and its side effects are limited to the treated area.

Your radiation treatments will be overseen by a radiation oncologist, a cancer doctor who specializes in radiation therapy.

In this section you can learn more about radiation therapy, including:

This Strong Mom Lost a Breast to Cancer, And the Photo of Her Breastfeeding Her Son Has Gone Viral

http://blog.thebreastcancersite.com/one-breast-feeding/

“I can’t begin to explain how this feels every day to be able to breastfeed my son, after losing one breast to cancer and being told I may not ever have this sweet boy in my arms.”… Read More

Full credit to the source URL for this article; please feel free to follow the link through to the full article.

Read More

Perjeta

https://www.breastcancer.org/treatment/targeted_therapies/perjeta

Perjeta (chemical name: pertuzumab) is approved by the U.S. Food and Drug Administration (FDA) to be used in combination with Herceptin (chemical name: trastuzumab), another targeted therapy medicine, and Taxotere (chemical name: docetaxel), a type of chemotherapy, to treat HER2-positive, metastatic breast cancer that hasn’t been treated with either Herceptin or chemotherapy yet. (Perjeta was called Omnitarg in earlier studies.)

Perjeta also is approved:

  • to be used in combination with Herceptin and Taxotere before surgery to treat HER2-positive, early-stage (the cancer must be larger than 2 cm or cancer must be in the lymph nodes), inflammatory, or locally advanced-stage breast cancer with a high risk of metastasizing or becoming fatal
  • to be used in combination with Herceptin and
    chemotherapy after surgery to treat HER2-positive, early-stage
    breast cancer with a high risk of recurrence

Doctors call treatments given before surgery neoadjuvant treatments and treatments given after surgery adjuvant treatments.

In this section you can learn more about:

<img src="https://www.breastcancer.org/system/images/assets/000/000/811/original/Community_board_BTN_4.png?1487270037" alt="Join the Conversation"…

Full credit to the source URL for this article; please feel free to follow the link through to the full article.

Read More

Join the Community

https://www.breastcancer.org/community/discussion

<!–
Start of DoubleClick Floodlight Tag: Please do not remove
Activity name of this tag: English Community – F/W2012
URL of the webpage where the tag is expected to be placed: http://www.breastcancer.org/community/
This tag must be placed between the and tags, as close as possible to the opening tag.
Creation Date: 08/28/2012
–>

Community

Our Community and Discussion Boards have registered members from around the world, and many more who simply browse the stories, support, and information that is offered — 24 hours a day, 7 days a week. Register now to complete your profile and start posting!

When you register, you will be asked only for a user name, password, and your email address. We will not use your email address to send unsolicited emails or provide it to any third parties. We ask for this information so we can better monitor activity in the Discussion Boards and exclude disruptive visitors. You will also be asked to agree to the rules for posting, as well as the terms of use. To receive recommended articles, you will need to complete diagnostic and treatment information in My Profile.

If you have further questions, please refer to our Privacy Policy.

Read the Community Guidelines.

Go to the Community.

Full credit to the source URL for this article; please feel free to follow the link through to the full article.

Read More

Proton Beam Therapy: The Futuristic Cancer Treatment That Could Improve Outcomes–If You Can Get It Approved

http://blog.thebreastcancersite.com/proton-beam-therapy/

It sounds like something out of a sci-fi movie, but proton beam therapy is effective, painless, and offers fewer side effects than traditional radiation. Then why isn’t it easier to get?… Read More

Full credit to the source URL for this article; please feel free to follow the link through to the full article.

Read More